Retatrutide, a new molecule, is generating considerable buzz in both Australia and the USA . This specific therapy combines GLP-1 and GIP receptor agonists , demonstrating significant outcomes in early medical studies for reducing excess weight. Experts believe this treatment offers a potential solu